Search results
Results from the WOW.Com Content Network
The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population (and ...
In May 2020, Indian Council of Medical Research's (ICMR's) National Institute of Virology approved and provided the virus strains for developing an Indian COVID-19 vaccine. [ 25 ] [ 26 ] In June 2020, the company received permission to conduct Phase I and Phase II human trials of a developmental COVID-19 vaccine codenamed BBV152 , from the ...
Singapore had relatively few COVID-19 cases before the emergence of the Delta and Omicron variants from 8 May 2021 to 29 March 2022. [2] With its relative success in curbing the early spread of the virus in Singapore, the term "circuit breaker" and its measures was subsequently adopted by other countries, particularly in Canada and the United ...
Singapore has more than 300,000 migrant workers living in cramped and unsanitary dormitories - with often 12 or 20 to a room. Rights groups have also criticised the government’s initial policy ...
Caregivers of COVID-19 patients also show a higher than average prevalence of mental health concerns. [2] These symptoms result from multiple different factors. SARS-Coronavirus-2 (SARS-CoV-2) directly infects olfactory neurons (smell) and nerve cells expressing taste receptors .
Since the COVID-19 pandemic, it may seem everyone is exploring mental health therapy, but men are being left behind. In the United States, young adults aged 18 to 34 who sought such therapy ...
9 January: In the wake of China's reopening, Health Minister Ong Ye Kung announced that travelers from China to Singapore would not be required to undergo pre-departure COVID-19 testing. [5] 16 January: The Pfizer-BioNTech/Comirnaty vaccine will be available to children aged six months to four years. [4]
On 20 August 2021, India granted emergency authorization to Zydus Cadila's vaccine ZyCoV-D, the world's first DNA plasmid-based COVID-19 vaccine, for patients 12 and older. India granted emergency use approval to the world's first DNA based COVID-19 vaccine, manufactured by for adults and children aged 12 years and above. The vaccine is ...